FORDHAM UNIVERSITY - Fordham College at Lincoln Center
May 2011
Specialities:
B.A. in Theatre- Directing
Skills
Microsoft Office • iWork • Social Media • Mac • PC • Facebook Insights • Heavy Phone volume. Working knowledge of... • Photoshop • Final Cut • Aperture • various software. Strong Collaborator/ T... • Well-organized • Detail Oriented • Dependable • Strong Sense of Creativity • Eager to learn.
2007 to 2000 Theatre/ Video ProductionViacom New York, NY Sep 2010 to Dec 2010 Intern- VH1 Digital Media ProductionACTOR'S FEDERAL CREDIT UNION New York, NY Jan 2009 to Sep 2010 Collections Clerk
Education:
FORDHAM UNIVERSITY - Fordham College at Lincoln Center May 2011 B.A. in Theatre- Directing
Skills:
Microsoft Office, iWork, Social Media, Mac, PC, Facebook Insights, Heavy Phone volume. Working knowledge of Lighting/ Sound/ Projection Equipment, Photoshop, Final Cut, Aperture, various software. Strong Collaborator/ Team-Player; Fast Learner, Well-organized, Detail Oriented, Dependable, Strong Sense of Creativity, Eager to learn.
Us Patents
Crystalline 9-E-(O-Methyl)Oxime Of 11, 12-Dideoxy-3-De(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-.Alpha.-L-Ribohexopyrano Syloxy)-6-O-Methyl-12,11-(Iminocarbonyl-(2-(3-(4-(3-Pyridinyl)1H-Imadazol-1 -Yl)Propyl)Hydrazono))-3-Oxoerythromycin
Wei-Guo Su - East Lyme CT Takushi Kaneko - Guilford CT Yong-Jin Wu - Madison CT Daniel J. Durkin - San Francisco CA Kathleen T. Smyth - West Roxbury MA
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3170 C07H 1708
US Classification:
514 29
Abstract:
The invention relates to crystalline 9-E-(O-methyl)oxime of 11,12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-. alpha. -L-ribohexopyr anosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)-1H-imidaz ol-1-yl)propyl)hydrazono))-3-oxoerythromycin wherein said crystalline compound is as the free base of said compound, the hemihydrate of said compound or the mesylate (methanesufonic acid) salt of said compound. The invention also relates to pharmaceutical compositions containing the foregoing crystalline compound and to methods of treating bacterial and protozoa infections by administering said crystalline compound.